Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the ...
As the property security landscape evolves, Cloudastructure is strategically expanding its salesforce to address growing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback